You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MET

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors Trial (ABN401)

Not yet recruiting
  • Neoplasms
  • (no location specified)
May 21, 2023

NSCLC Trial in Guangzhou (Savolitinib, Docetaxel)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Department of Thoracic Surgery and Oncology, The First Affiliate
Mar 17, 2023

NSCLC, BRAF V600 Mutation, MET Exon 14 Mutation Trial in Guangzhou (Dabrafenib + Trametinib, Capmatinib)

Not yet recruiting
  • NSCLC
  • +2 more
  • Guangzhou, Guangdong, China
    Cancer Center of Sun-Yat Sen University
Sep 19, 2023

Mental Health Issue, Mental Health Wellness 1 Trial in London (MeT4VeT mobile phone app: control, MeT4VeT mobile phone app:

Completed
  • Mental Health Issue
  • Mental Health Wellness 1
  • MeT4VeT mobile phone app: control
  • MeT4VeT mobile phone app: intervention
  • London, United Kingdom
    King's College London
Aug 8, 2023

Cesarean Section Complications Trial in Lahore (Mobilization, Muscle Energy Technique (MET))

Recruiting
  • Cesarean Section Complications
  • Mobilization
  • Muscle Energy Technique (MET)
  • Lahore, Punjab, Pakistan
    Chaudary Muhammad Akram Teaching Hospital, Azra Naheed Medical C
May 23, 2023

Non-squamous Non-small-cell Lung Cancer, Stage IV NSCLC, ROS1 Gene Rearrangement Trial in Toronto (Crizotinib)

Recruiting
  • Non-squamous Non-small-cell Lung Cancer
  • +4 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

NSCLC Metastatic Trial in Seoul (Lazertinib, Tepotinib)

Not yet recruiting
  • Non-Small Cell Lung Cancer Metastatic
  • Seoul, Gangnam-gu, Korea, Republic of
    Samsung Medical Center
Oct 27, 2023

NSCLC Trial in Guangzhou (PLB1001)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Aug 15, 2023

NSCLC Trial (HS-10241+ Almonertinib, Pemetrexed + Cisplatin /Carboplatin)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • HS-10241+ Almonertinib
  • Pemetrexed + Cisplatin /Carboplatin
  • (no location specified)
Oct 29, 2023

Lung Non-Small Cell Carcinoma Trial (Amivantamab, Biospecimen Collection, Computed Tomography)

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • Amivantamab
  • +3 more
  • (no location specified)
Oct 30, 2023

NSCLC Trial in Houston (Amivantamab, Tepotinib)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Houston, Texas
    MD Anderson Cancer Center
Oct 9, 2023

Gastric Cancer, Gastroesophageal-junction Cancer Trial in Gyeonggi-do (Tepotinib plus paclitaxel)

Recruiting
  • Gastric Cancer
  • Gastroesophageal-junction Cancer
  • Tepotinib plus paclitaxel
  • Gyeonggi-do, Korea, Republic of
    Hallym University Medical Center
Jun 29, 2022

Heel Pain Syndrome Trial in Ghakhar (MET PIR with Dry Needling, MET PIR without Dry Needling)

Recruiting
  • Heel Pain Syndrome
  • MET PIR with Dry Needling
  • MET PIR without Dry Needling
  • Ghakhar, Punjab, Pakistan
    Fatima Bashir Hospital
Oct 11, 2023

Advanced Head and Neck Squamous Cell Carcinoma Trial (Pembrolizumab, MET-4, Placebo)

Not yet recruiting
  • Advanced Head and Neck Squamous Cell Carcinoma
  • (no location specified)
Feb 22, 2023

Stomach Cancer, Adenocarcinoma Trial in Seoul (Durvalumab, Savolitinib)

Recruiting
  • Stomach Cancer, Adenocarcinoma
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jan 10, 2023

Solid Tumor Trial in Bengbu (SPH 3348)

Recruiting
  • Solid Tumor
  • SPH 3348
  • Bengbu, Anhui, China
    The First Affliated Hospital of Bengbu Medical College
Jul 25, 2022

NSCLC Trial in Pittsburgh (Capmatinib)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jan 9, 2023

Colorectal Cancer Metastatic, C-met Overexpression Trial in Rozzano (Tivantinib (ARQ197))

Completed
  • Colorectal Cancer Metastatic
  • C-met Overexpression
  • Tivantinib (ARQ197)
  • Rozzano, Milano, Italy
    Istituto Clinico Humanitas
Sep 8, 2022

Tumor of Stomach Trial in Shanghai (Met exercises)

Recruiting
  • Neoplasm of Stomach
  • Met exercises
  • Shanghai, Shanghai, China
    Ruijin Hospital
Jan 25, 2023

Metastatic NSCLC MET Exon 14 Skipping Mutation and Brain

Completed
  • Metastatic Non-Small Cell Lung Cancer
  • East Hanover, New Jersey
    18 Novartis Investigative Sites in the US
Dec 29, 2022

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, biological, drug)

Not yet recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Sep 7, 2023

Novel FLUorescENt C-mEt Tracer in Penile and Tongue

Completed
  • Head and Neck Cancer
  • Penile Cancer
    • Amsterdam, Noord-Holland, Netherlands
      The Netherlands Cancer Institute / Antoni van Leeuwenhoek
    Oct 18, 2022

    Malignant Non-small Cell Tumor of Lung Stage IV Trial in Boston (Capmatinib (INC280))

    Completed
    Has Results
    • Malignant Non-small Cell Neoplasm of Lung Stage IV
    • Capmatinib (INC280)
    • Boston, Massachusetts
      Massachusetts General Hospital
    Mar 11, 2022

    Type 2 Diabetes Trial in Daejeon (CT-L01, Alogliptin Benzoate 25 mg, Metformin HCl XR 1,000 mg)

    Completed
    • Healthy
    • Daejeon, Korea, Republic of
      Chungnam National University Hospital
    Jan 10, 2023

    NSCLC Trial (Telisotuzumab Vedotin, Osimertinib, Cisplatin)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • Telisotuzumab Vedotin
    • +4 more
    • (no location specified)
    Oct 17, 2023